Berkshire Hathaway Sells DaVita Shares, Hinting at Strategic Re‑balance and Market Watch Ahead of Q2 Report
Explore why Berkshire Hathaway’s recent DaVita sale signals a strategic review, its valuation implications, and how investors should respond.
3 minutes to read